Publications by authors named "Li Liang-Shan"
Purpose: To compare the safety and efficacy of CPG in the rectus abdominis and intercostal regions.
Materials And Methods: This retrospective study included 226 patients who underwent CPG at a single center, with the stoma placed in the rectus abdominis or intercostal region. Surgical outcomes and complications, such as pain and infection within 6 months postoperatively, were recorded.
Purpose: To investigate the safety and efficacy of iodine-125 seed implantation in the treatment of abdomen-thorax desmoid tumors (DTs).
Methods And Materials: Data from 14 DT patients who received brachytherapy with iodine-125 seeds were retrospectively collected from 2014 to 2020. The operation was completed using CT guidance and the treatment plan system (TPS).
Article Synopsis
- - Aggressive angiomyxoma (AAM) is a rare and locally aggressive tumor that often returns after surgery; the study explored a new chemical ablation method as a potential treatment option.
- - The study involved two female patients between 2012 and 2016, where various amounts of anhydrous ethanol and glacial acetic acid were used for the ablation process, with details on complications recorded.
- - While complete resection is the standard treatment for AAM, the study suggests that chemical ablation may serve as a promising adjunct therapy; however, further research is necessary to validate these results.
Background: This study evaluated the clinical efficacy of computed tomography (CT)-guided radioactive iodine-125 ( I) seed implantation in patients with metastatic epidural spinal cord compression (MESCC).
Materials And Methods: A cohort of 22 patients with MESCC were retrospectively enrolled. All patients underwent CT-guided I seed implantation therapy via standard procedures.
There are no large samples or exact prediction models for assessing the cancer risk factors of solitary pulmonary nodules (SPNs) in the Chinese population. We retrospectively analyzed the clinical and imaging data of patients with SPNs who underwent computer tomography guided needle biopsy in our hospital from Jan 1st of 2011 to March 30th of 2016. These patients were divided into a development data set and a validation data set.
View Article and Find Full Text PDF